Koninklijke Philips (AMS:PHIA) has been assigned a €42.00 ($48.84) target price by investment analysts at UBS Group in a report released on Thursday, www.boersen-zeitung.de reports. The firm currently has a “buy” rating on the stock. UBS Group’s price target would indicate a potential upside of 28.36% from the company’s previous close.
PHIA has been the subject of several other research reports. JPMorgan Chase & Co. set a €39.80 ($46.28) price target on shares of Koninklijke Philips and gave the company a “neutral” rating in a research note on Tuesday, July 17th. Credit Suisse Group set a €40.00 ($46.51) price objective on shares of Koninklijke Philips and gave the stock a “neutral” rating in a report on Tuesday, October 2nd. Morgan Stanley set a €36.00 ($41.86) price objective on shares of Koninklijke Philips and gave the stock a “neutral” rating in a report on Tuesday, October 23rd. HSBC set a €44.00 ($51.16) price objective on shares of Koninklijke Philips and gave the stock a “buy” rating in a report on Tuesday, August 7th. Finally, Cfra set a €35.00 ($40.70) price objective on shares of Koninklijke Philips and gave the stock a “neutral” rating in a report on Monday, October 22nd. Six analysts have rated the stock with a hold rating and eleven have given a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average price target of €39.62 ($46.07).
Shares of Koninklijke Philips stock traded up €0.97 ($1.13) during mid-day trading on Thursday, hitting €32.72 ($38.05). The stock had a trading volume of 4,210,000 shares, compared to its average volume of 3,650,000. Koninklijke Philips has a 12-month low of €28.92 ($33.63) and a 12-month high of €36.12 ($42.00).
Koninklijke Philips N.V. is the Netherlands-based health technology company. The Company’s segments include Personal Health businesses, Diagnosis & Treatment businesses, Connected Care & Health Informatics businesses, HealthTech Other and Legacy Items. The Personal Health businesses segment is engaged in the health continuum, delivering integrated, connected solutions that support healthier lifestyles and those living with chronic disease.
Read More: How to invest in a bear market
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.